# Elicio Therapeutics (ELTX) — Earnings

ELTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eltx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.60 |
| EPS estimate | −$0.48 |
| EPS surprise | −25.00% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1601485/000160148525000124/angn-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 13, 2025 | −$0.48 | −$0.60 | -25.00% | — | — |
| Q2 2025 | Aug 7, 2025 | −$0.69 | −$0.66 | 3.65% | — | — |
| Q1 2025 | May 13, 2025 | −$0.83 | −$0.87 | -4.82% | — | — |
| Q4 2024 | Mar 31, 2025 | −$0.88 | −$1.07 | -22.29% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.73 | −$1.39 | -90.41% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.96 | −$0.64 | 33.33% | — | — |
| Q1 2024 | May 15, 2024 | −$1.09 | −$1.15 | -5.50% | — | — |
| Q4 2023 | Mar 29, 2024 | −$1.03 | −$1.25 | -21.36% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.80 | −$1.27 | -58.75% | — | — |
| Q2 2023 | Aug 11, 2023 | −$5.70 | −$2.61 | 54.21% | $800,000.00 | — |
| Q3 2022 | Nov 14, 2022 | −$3.20 | −$3.00 | 6.25% | $625,000.00 | — |
| Q2 2022 | Aug 15, 2022 | −$4.63 | −$3.00 | 35.25% | $1.4M | $653,000.00 |
| Q1 2022 | May 16, 2022 | −$4.35 | −$4.80 | -10.34% | $918,750.00 | $1.6M |
| Q4 2021 | Mar 30, 2022 | −$3.28 | $5.00 | 252.67% | $7.4M | $25.9M |
| Q3 2021 | Nov 12, 2021 | −$7.25 | −$5.30 | 26.90% | $1.1M | $1.5M |
| Q2 2021 | Aug 12, 2021 | −$6.88 | −$5.80 | 15.64% | $787,500.00 | $540,000.00 |
| Q1 2021 | May 17, 2021 | −$6.23 | −$15.60 | -150.60% | $1.9M | $371,000.00 |
| Q4 2020 | Mar 30, 2021 | −$13.23 | −$19.00 | -43.67% | $753,000.00 | $479,500.00 |

## Frequently Asked Questions

### When did Elicio Therapeutics (ELTX) last report earnings?

Elicio Therapeutics last reported on Nov 13, 2025, covering fiscal Q3 2025.

### Did ELTX beat earnings estimates?

No. Elicio Therapeutics reported EPS of −$0.60 for Q3 2025 against a −$0.48 estimate — a 25.00% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).